Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MacroGenics discloses novel diabodies for the treatment of cancer

Dec. 19, 2012

Roche's Perjeta receives CHMP recommendation for approval

Dec. 18, 2012

Intracellular mechanisms of glycolysis-mediated tumor growth discovered

Dec. 18, 2012

Bayer Intellectual Property describes novel MKNK1 inhibitors

Dec. 18, 2012

Spanish researchers synthesize new protein kinase inhibitors

Dec. 18, 2012

Japanese researchers present novel adenovirus vectors for cancer

Dec. 18, 2012

University of Michigan patents novel antibodies binding to integrin alpha-2

Dec. 18, 2012

Novel inhibitor of IDH1/2 shows therapeutic potential in the treatment of AML

Dec. 17, 2012

AXL inhibitors show efficacy in leukemia

Dec. 17, 2012

Bay-846, a potential new treatment for malignant brain tumors

Dec. 17, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...